592 related articles for article (PubMed ID: 19628340)
1. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma.
Hatanaka K; Nakamura N; Kojima M; Ando K; Irie S; Bunno M; Nakamine H; Uekusa T
Pathol Res Pract; 2010 Jan; 206(1):9-13. PubMed ID: 19628340
[TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
[TBL] [Abstract][Full Text] [Related]
3. Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients.
Kojima M; Motoori T; Nakamura S
Biomed Pharmacother; 2006 Dec; 60(10):663-72. PubMed ID: 17064872
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-associated lymphoproliferative disorders of the tongue developing in patients with rheumatoid arthritis: a report of 2 cases and a review.
Hashimoto K; Nagao T; Saito T; Kinoshita H
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):e1-5. PubMed ID: 24927637
[TBL] [Abstract][Full Text] [Related]
5. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
6. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression.
Attygalle AD; Kyriakou C; Dupuis J; Grogg KL; Diss TC; Wotherspoon AC; Chuang SS; Cabeçadas J; Isaacson PG; Du MQ; Gaulard P; Dogan A
Am J Surg Pathol; 2007 Jul; 31(7):1077-88. PubMed ID: 17592275
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
[TBL] [Abstract][Full Text] [Related]
8. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.
Skugor ND; Perić Z; Vrhovac R; Radić-Kristo D; Kardum-Skelin I; Jaksić B
Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection.
Lioté F; Pertuiset E; Cochand-Priollet B; D'Agay MF; Dombret H; Numéric P; D'Anglejan G; Kuntz D
J Rheumatol; 1995 Jun; 22(6):1174-8. PubMed ID: 7674250
[TBL] [Abstract][Full Text] [Related]
10. CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy.
Hatachi S; Kunitomi A; Aozasa K; Yagita M
Mod Rheumatol; 2010 Oct; 20(5):500-5. PubMed ID: 20437072
[TBL] [Abstract][Full Text] [Related]
11. [2-year complete remission after withdrawal of methotrexate in a rectal methotrexate-associated diffuse large B-cell lymphoma].
Ogasawara T; Kimura A; Yasuyama M; Ohtuka K; Aiba M; Kawauchi K
Rinsho Ketsueki; 2007 Jun; 48(6):485-90. PubMed ID: 17633096
[TBL] [Abstract][Full Text] [Related]
12. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients.
Kojima M; Motoori T; Asano S; Nakamura S
Pathol Res Pract; 2007; 203(6):423-31. PubMed ID: 17540509
[TBL] [Abstract][Full Text] [Related]
13. Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases.
Kojima M; Itoh H; Hirabayashi K; Igarashi S; Tamaki Y; Murayama K; Ogura H; Saitoh R; Kashiwabara K; Takimoto J; Masawa N; Nakamura S
Pathol Res Pract; 2006; 202(9):679-85. PubMed ID: 16859835
[TBL] [Abstract][Full Text] [Related]
14. Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection.
Miyazaki T; Fujimaki K; Shirasugi Y; Yoshiba F; Ohsaka M; Miyazaki K; Yamazaki E; Sakai R; Tamaru J; Kishi K; Kanamori H; Higashihara M; Hotta T; Ishigatsubo Y
Am J Hematol; 2007 Dec; 82(12):1106-9. PubMed ID: 17654684
[TBL] [Abstract][Full Text] [Related]
15. EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with methotrexate.
Hsiao SC; Ichinohasama R; Lin SH; Liao YL; Chang ST; Cho CY; Chuang SS
Pathol Res Pract; 2009; 205(1):43-9. PubMed ID: 18951733
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated lymphoproliferative disorder in a patient with rheumatoid arthritis on methotrexate and rofecoxib: idiosyncratic reaction or pharmacogenetics?
Vincent S; Slease RB; Rocca PV
Del Med J; 2002 Dec; 74(12):469-73. PubMed ID: 15595320
[TBL] [Abstract][Full Text] [Related]
17. In immunocompromised patients, Epstein-Barr virus lymphadenitis can mimic angioimmunoblastic T-cell lymphoma morphologically, immunophenotypically, and genetically: a case report and review of the literature.
Steciuk MR; Massengill S; Banks PM
Hum Pathol; 2012 Jan; 43(1):127-33. PubMed ID: 21733557
[TBL] [Abstract][Full Text] [Related]
18. Histological varieties of Epstein-Barr virus-related lymph node lesion resembling autoimmune disease-like clinicopathological findings in middle-aged and elderly patients: a study of six cases.
Kojima M; Sugiura I; Itoh H; Shimizu K; Murayama K; Motoori T; Shimano S; Masawa N; Nakamura S
Pathol Res Pract; 2006; 202(8):609-15. PubMed ID: 16824704
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritis.
Kikuchi K; Miyazaki Y; Tanaka A; Shigematu H; Kojima M; Sakashita H; Kusama K
Head Neck Pathol; 2010 Dec; 4(4):305-11. PubMed ID: 20676828
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]